|Bid||13.35 x 3200|
|Ask||13.34 x 900|
|Day's Range||13.25 - 14.12|
|52 Week Range||8.50 - 18.10|
|Beta (3Y Monthly)||4.59|
|PE Ratio (TTM)||182.47|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Supreme Cannabis Co. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) and Blissco Cannabis (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B:GR) have entered into an arrangement agreement under which Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco not already owned by the company by way of a court-approved plan of arrangement under […]The post Cannabis Stock News Daily Roundup May 17 appeared first on Market Exclusive.
VANCOUVER, May 16, 2019 /PRNewswire/ - Village Farms International, Inc. ("Village Farms" or the "Company") (VFF) (VFF) applauds the passage yesterday by a unanimous vote of House Bill 1325 ("HB 1325" or "the Bill") today by the Texas State Senate. HB 1325 is a bi-partisan bill that, if passed into law, will establish a Texas Hemp Program, providing a regulatory and licensing framework for the cultivation and processing of hemp, as well as for products made from hemp, including cannabidiol (CBD). On April 24, 2019, HB 1325 was unanimously passed by the Texas State House of Representatives.
Despite a nearly 15% post-earnings pop, there's little substance in this marijuana stock's latest operating results.
NEW YORK, May 14, 2019 -- Pomerantz LLP is investigating claims on behalf of investors of Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF)..
On CNBC's "Mad Money Lightning Round," Jim Cramer said he would hold off for now from Village Farms International Inc (NASDAQ: VFF ). He is not a buyer of Sailpoint Technologies Holdings Inc ...
It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed. Want to take a deep dive into Cramer's world?
Village Farms International Reports First Quarter 2019 Results - Canadian Cannabis Joint Venture, Pure Sunfarms, Achieves Second Consecutive Quarter of Profitability
VANCOUVER, May 7, 2019 /PRNewswire/ - Village Farms International, Inc. ("Village Farms" or the "Company") (VFF) (VFF) today announced Michael DeGiglio, Chief Executive Officer, will present at Canaccord Genuity's 3rd Annual Cannabis Conference on Tuesday, May 14, 2019 at the Grand Hyatt New York in New York City at 12:20 p.m. ET. Village Farms' presentation will be available via a live webcast at http://wsw.com/webcast/canaccord34/vff/. Mr. DeGiglio and Village Farms' Chief Financial Officer, Stephen Ruffini, are also available for one-on-one meetings at the conference.
Today we'll look at Vereinigte Filzfabriken AG (MUN:VFF) and reflect on its potential as an investment. In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is...
VANCOUVER, April 24, 2019 /PRNewswire/ - Village Farms International, Inc. ("Village Farms" or the "Company") (VFF) (VFF) applauds the passage of House Bill 1325 ("HB 1325") today by the Texas State House of Representatives. HB 1325 is a bi-partisan bill that, if passed into law, will establish a Texas Hemp Program, providing a regulatory and licensing framework for the cultivation and processing of hemp, as well as for products made from hemp, including cannabidiol (CBD). HB 1325 will now proceed to the Texas Senate, where, if passed out of Committee after a hearing, it will be voted upon on the Senate floor. "We are encouraged by this positive step towards potentially establishing a legal hemp program in the State of Texas, which will enable Village Farms to leverage its extensive, large-scale greenhouse operations and 30 years of experience as a vertically integrated produce grower for both greenhouse and outdoor hemp production in Texas," said Michael DeGiglio, Chief Executive Officer, Village Farms.
VANCOUVER, April 23, 2019 /PRNewswire/ - Village Farms International, Inc. ("Village Farms" or the "Company") (VFF) (VFF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has, on schedule, completed planting of Quadrants 1 and 4 of its 1.1 million square foot Delta 3 greenhouse operation in Delta, BC. As a result, the entire 1.03 million square feet of growing area at the Delta 3 facility (composed of 16 individual grow rooms) is now in production. Pure Sunfarms remains on track to achieve full run rate annual production of 75,000 kilograms at the Delta 3 greenhouse operation by mid-2019. "With the support of Village Farms' decades of experience developing and ramping up large-scale growing operations, the Pure Sunfarms team continues to execute on plan," said Michael DeGiglio, Chief Executive Officer, Village Farms.
April may bring spring showers, but it still feels like winter for marijuana stock investors. This month has rained almost entirely bad news down on the cannabis sector, and investors haven't spared Cronos Group (NASDAQ:CRON) from the selling deluge.Source: Shutterstock Aphria's (NASDAQ:APHA) dour earnings report further damaged the mood, casting a wide shadow over other industry players. Companies like Tilray (NASDAQ:TLRY) and Canopy Growth (NYSE:CGC) saw their share prices wilt as people began to adjust their outlook for this earnings season downward. And there was the latest short seller target as well, with Village Farms (NASDAQ:VFF) losing as much as 15% of its value following a negative report from Citron.On Wednesday, all signs pointed to even more trouble for CRON stock in particular. That's because BofA/Merrill Lynch launched coverage of several leading marijuana stocks. It gave favorable coverage to two, while slapping CRON stock with an underperform rating. Normally, you'd expect CRON stock to slump on the news. Instead, shares dipped a bit and then rallied, actually closing the day in the green. It could be a positive sign for the company going forward that it could rebound following bad news.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Worried About Valuation for CRON StockBofA's report was hardly all that negative on Cronos as a company. They like its prospects, but the share price is a hang-up. They wrote: "We initiate coverage of Cronos, a Canada based cannabis company, with an Underperform rating and […] $13 price objective". * 10 S&P 500 Stocks to Weather the Earnings Storm They arrived at this price target in large part on an enterprise value to sales metric. They plugged in their 2020 estimate for sales and slapped a 23x multiple on said figure, which worked out to a $13 price target.As I said, BofA isn't down on the company. Their analysts added that, "Cronos is a compelling fundamental value in our view, but we are unable to get comfortable with the valuation." That's fair. The marijuana stocks are all highly valued and require some faith in the overall cannabis story to get behind.On the other hand, it's not like BofA views the whole sector as overvalued. At the same time that it panned Cronos on valuation, it gave a buy rating to Aurora Cannabis (NYSE:ACB) suggesting that it will be one of the "few truly global" companies in pot. Interestingly, even using just a 17x EV/sales multiple, they got to an $11 price target for ACB stock. BofA was even more optimistic for Canopy Growth, suggesting it is worth 24x EV/sales, which gets to a price objective of $52. So, for as fundamentally bullish as BofA may be on Cronos, they like some of its competition a whole lot more. Need A Better Earnings ReportCRON stock owners come into this earnings season with an extra dose of trepidation. That's because, arguably, Cronos delivered the single worst earnings report of all the marijuana majors during the last quarterly earnings report cycle. Given that APHA stock is now down 25% in recent days following its clunker of an earnings release, the market is saying companies need to shape up or their share prices will get leveled.Turning back to Cronos, its last report showed some flaws in the business model. Remember that Citron Research had previously blasted Cronos for having tiny distribution deals compared to rivals. Cronos' last earnings showed minimal recreational marijuana revenues. While overall revenues grew sharply, it appears that Cronos is still reliant on medicinal for the time being. Anyone who was thinking Cronos would see business results soar on Canada's legalization has been disappointed -- at least for the time being.Cronos also appears to be suffering from the same margin compression that has hit its rivals. Over the past three quarters, its gross margin has fallen from 63% to 55% and now just 45% during the most recent one. As the flood of marijuana supply comes online, they will have to demonstrate that they can keep their profit margins up. Otherwise, it could be rough days ahead for CRON stock. CRON Stock: Don't Forget About AltriaThat said, the bears risk claiming victory too early here. Sure, CRON stock has slumped from a high of $25 to $16 now. The marijuana sector as a whole is in a bit of a slump. But we're arguably still in the early innings of the marijuana stocks story playing out.Some folks have said that Canada's legalization was the top for the sector, and that it's all downhill from here. But I think we'll see a different path. Yes, a lot of marijuana companies are going to go out of business. There are way too many companies fighting over what is still a small and new market at the moment. There will be consolidation. Businesses will fail.This is great news for the sector leaders, however. As there are more mergers and acquisitions, the leaders will become more and more powerful. Cronos, along with Canopy, are set to be those industry leaders. By virtue of having the biggest backers and access to cheap and plentiful capital, Canopy and Cronos have the best chance of taking leadership in the marijuana industry. Sure, Cronos has a lot to fix based on its recent earnings reports. But with Altria's (NYSE:MO) help, there's no reason to count out CRON stock yet.At the time of this writing, Ian Bezek owned MO stock. You can reach him on Twitter at @irbezek. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Dividend Stocks Perfect for Retirees * 7 Reasons the Stock Market Rally Isn't Over Yet * 10 S&P 500 Stocks to Weather the Earnings Storm Compare Brokers The post Cronos Stock Shrugs Off Negative Analyst Report appeared first on InvestorPlace.
VANCOUVER , April 18, 2019 /CNW/ - Village Farms International, Inc. ("Village Farms" or the "Company") (VFF) (VFF) announced today that it has completed its previously announced bought deal offering of 1,000,000 common shares (the "Offered Shares") in the capital of the Company at a price of $20.00 per Offered Share for aggregate gross proceeds to the Company of $20,000,000 (the "Offering"). The Offering was conducted by a syndicate of underwriters led by Beacon Securities Limited, and including Canaccord Genuity Corp. and GMP Securities L.P. The Company intends to use the net proceeds for working capital purposes, including the growth capital needs of the Company's U.S. hemp business.